Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMOZOLOMIDE Cause Acute respiratory failure? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Acute respiratory failure have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.1% of all adverse event reports for TEMOZOLOMIDE.

23
Reports of Acute respiratory failure with TEMOZOLOMIDE
0.1%
of all TEMOZOLOMIDE reports
9
Deaths
21
Hospitalizations

How Dangerous Is Acute respiratory failure From TEMOZOLOMIDE?

Of the 23 reports, 9 (39.1%) resulted in death, 21 (91.3%) required hospitalization, and 2 (8.7%) were considered life-threatening.

Is Acute respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does TEMOZOLOMIDE Cause?

Disease progression (1,562) Death (1,403) Off label use (1,357) Product use in unapproved indication (1,353) Thrombocytopenia (1,300) Drug ineffective (1,131) Nausea (1,071) Neutropenia (809) Malignant neoplasm progression (779) Fatigue (766)

What Other Drugs Cause Acute respiratory failure?

PREDNISONE (645) TREPROSTINIL (484) MACITENTAN (422) TACROLIMUS (414) AMBRISENTAN (402) DEXAMETHASONE (384) RIVAROXABAN (361) RITUXIMAB (351) MYCOPHENOLATE MOFETIL (347) METHOTREXATE (321)

Which TEMOZOLOMIDE Alternatives Have Lower Acute respiratory failure Risk?

TEMOZOLOMIDE vs TEMSIROLIMUS TEMOZOLOMIDE vs TENAMFETAMINE TEMOZOLOMIDE vs TENAPANOR TEMOZOLOMIDE vs TENECTEPLASE TEMOZOLOMIDE vs TENELIGLIPTIN

Related Pages

TEMOZOLOMIDE Full Profile All Acute respiratory failure Reports All Drugs Causing Acute respiratory failure TEMOZOLOMIDE Demographics